Regulatory pathway for Medical Devices QbD Timeline 2019 2018 - - PowerPoint PPT Presentation

regulatory pathway for medical devices qbd timeline
SMART_READER_LITE
LIVE PREVIEW

Regulatory pathway for Medical Devices QbD Timeline 2019 2018 - - PowerPoint PPT Presentation

Regulatory pathway for Medical Devices QbD Timeline 2019 2018 France 2017 Colombia 2016 QbD Sales office USA Spain Software 2013 & Mexico The Netherlands 2011 Belgium +200 Employees +50 Clients QbD Fields of action Regulatory


slide-1
SLIDE 1

Regulatory pathway for Medical Devices

slide-2
SLIDE 2

2011 Belgium 2013 The Netherlands 2016 Spain & Mexico 2017 QbD Software 2018 Colombia Sales office USA

+200 Employees +50 Clients

QbD Timeline

2019 France

slide-3
SLIDE 3

QbD Fields of action

Validation Quality assurance Project management & support Regulatory affairs

expertises

slide-4
SLIDE 4

QbD client portfolio

Pharma Biotech Medical devices Cosmetics

slide-5
SLIDE 5

Steven Vinkx

Medical Device QA & regulatory project engineer

QMS implementation Certification regulatory strategy Project management Training

Lead auditor ISO13485:2016

slide-6
SLIDE 6

Medical Device Life Cycle

Ideation Design & Development Verification & Validation ISO 13485:2016 Design Transfer Device production Post Market

Design & Development

Design control

Manufacturing

Change Control

Feasibility

Regulatory approval

Research

Scope of regulatory compliance

Product registration process PMS

slide-7
SLIDE 7

Regulatory strategy

Intended use & risk

Three factors to determine go-to-market regulatory strategy

Intended market MD versus IVD

slide-8
SLIDE 8

Intended market

slide-9
SLIDE 9

Europe : CE marking

  • marking
slide-10
SLIDE 10

Medical Device or In Vitro Diagnostic ?

intended by the manufacturer to be used … for human beings …. for medical purposes … does not achieve its principal intended action by pharmacological, immunological or metabolic means … in or on the human body, but which may be assisted in its function …

Medical Device Regulation

… medical device to be used in vitro for the examination of specimens, …. derived from the human body …. solely or principally for the purpose of providing information …..

In Vitro Diagnostic Regulation

slide-11
SLIDE 11

Medical Device or In Vitro Diagnostic ?

Origin of input data? MD or IVD ? -> can be both

Software Integral versus standalone

More devices / platforms than you might expect!

slide-12
SLIDE 12

Software - Medical Device or IVD ?

Algorithm that generates a risk score to trigger care processes based on respiratory rate, heart rate, blood pressure, …

1

medical purpose in vivo monitoring

MD

Bio-informatics intended to analyze sequencing data coming from patient cancer genomes.

2

allows detection of genome alteration supports diagnosis and treatment decisions

IVD

IVD input

slide-13
SLIDE 13

Software - Medical Device or IVD ?

Software to be used for hospital staff planning and invoicing

3

no medical purpose

Generic

Qualification & classification guideline – MDCG (11/2019)

slide-14
SLIDE 14

Risk based classification

FDA vs MDR/EU Based on intended use / claim Correlation claim versus risk Higher class for higher risks

slide-15
SLIDE 15

Europe : Transition to MDR

May 2021

slide-16
SLIDE 16

Key MDR changes

slide-17
SLIDE 17

Key MDR changes

UDI EUDAMED (postponed) Classification

slide-18
SLIDE 18

Impact of COVID-19 pandemic

slide-19
SLIDE 19

Requests for «exceptional use»

On case-by-case patient & MD basis (e.g. respiratory devices)

“Compassionate use”

Request for a derogation on conformity assessment of NEW

  • Medical Devices & IVD’s
  • For the purpose of multiple patients
  • Under supervision of National Competent Authority (FAGG)

Derogation requests

slide-20
SLIDE 20

IVD Derogations

slide-21
SLIDE 21

IVD for Covid-19

SARS-CoV-2 Virus testing

Genetic material (PCR) Surface antigens Mostly automated Diagnosis & Treatment

Antibody testing

blablabla

Immune response Lower effectiveness & sensitivity Fast result Population Screening

Context & Intended purpose !

slide-22
SLIDE 22

MD (&PPE) Derogations

slide-23
SLIDE 23

More flexible regulatory approval

Medical Device Class Is (sterile)

Non-CE marked Surgical Masks are allowed under strict conditions

Availability only during crisis No use of regular distribution channels

slide-24
SLIDE 24

More flexible testing regime

Ideation Design & Development Verification & Validation ISO 13485:2016 Design Transfer Device production Post Market

Design & Development

Design control

Manufacturing

Change Control

Feasibility

Regulatory approval

Research

Scope of regulatory compliance

Product registration process PMS

slide-25
SLIDE 25

More flexible testing regime

Harmonized Standard

EN 14683

Design & Development Verification & Validation

Other standards also accepted

YY 0469:2011 and YY/T: 0969-2013 ASTM F2100 Alternative Testing Protocol

slide-26
SLIDE 26

Free ISO standards

https://www.iso.org/covid19

slide-27
SLIDE 27

Medical Device Life Cycle

Ideation Design & Development Verification & Validation ISO 13485:2016 Design Transfer Device production Post Market

Design & Development

Design control

Manufacturing

Change Control

Feasibility

Regulatory approval

Research

Scope of regulatory compliance

Product registration process PMS

Start in time ! Determine the applicable legislation Determine intended use & classification Implement lean & efficient QMS

slide-28
SLIDE 28

Thank you

slide-29
SLIDE 29